AU711630B2 - Carbohydrate derivatives - Google Patents

Carbohydrate derivatives Download PDF

Info

Publication number
AU711630B2
AU711630B2 AU20086/97A AU2008697A AU711630B2 AU 711630 B2 AU711630 B2 AU 711630B2 AU 20086/97 A AU20086/97 A AU 20086/97A AU 2008697 A AU2008697 A AU 2008697A AU 711630 B2 AU711630 B2 AU 711630B2
Authority
AU
Australia
Prior art keywords
carbohydrate derivative
carbohydrate
thrombin
composition
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU20086/97A
Other languages
English (en)
Other versions
AU2008697A (en
Inventor
Constant Adriaan Anton Boeckel Van
Pieter Westerduin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi SA
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA, Akzo Nobel NV filed Critical Sanofi SA
Publication of AU2008697A publication Critical patent/AU2008697A/en
Application granted granted Critical
Publication of AU711630B2 publication Critical patent/AU711630B2/en
Assigned to AKZO NOBEL N.V., SANOFI-SYNTHELABO reassignment AKZO NOBEL N.V. Alteration of Name(s) in Register under S187 Assignors: AKZO NOBEL N.V., SANOFI SOCIETE ANONYME
Assigned to SANOFI-SYNTHELABO reassignment SANOFI-SYNTHELABO Alteration of Name(s) in Register under S187 Assignors: AKZO NOBEL N.V., SANOFI-SYNTHELABO
Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Request to Amend Deed and Register Assignors: SANOFI-SYNTHELABO
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU20086/97A 1996-05-08 1997-05-06 Carbohydrate derivatives Expired AU711630B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201267 1996-05-08
EP96201267 1996-05-08

Publications (2)

Publication Number Publication Date
AU2008697A AU2008697A (en) 1997-11-13
AU711630B2 true AU711630B2 (en) 1999-10-21

Family

ID=8223964

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20086/97A Expired AU711630B2 (en) 1996-05-08 1997-05-06 Carbohydrate derivatives

Country Status (27)

Country Link
US (1) US5872110A (cs)
EP (1) EP0818459B1 (cs)
JP (1) JP4201360B2 (cs)
KR (1) KR100443802B1 (cs)
CN (1) CN1115345C (cs)
AR (1) AR007052A1 (cs)
AT (1) ATE215547T1 (cs)
AU (1) AU711630B2 (cs)
BR (1) BRPI9703099B8 (cs)
CA (1) CA2204204C (cs)
CZ (1) CZ292439B6 (cs)
DE (1) DE69711505T2 (cs)
DK (1) DK0818459T3 (cs)
ES (1) ES2176609T3 (cs)
HK (1) HK1004399A1 (cs)
HU (1) HU226370B1 (cs)
ID (1) ID17932A (cs)
IL (1) IL120722A (cs)
NO (1) NO308251B1 (cs)
NZ (1) NZ314745A (cs)
PL (1) PL183469B1 (cs)
PT (1) PT818459E (cs)
RU (1) RU2183638C2 (cs)
SG (2) SG55310A1 (cs)
TR (1) TR199700354A2 (cs)
TW (1) TW498078B (cs)
ZA (1) ZA973892B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69832066T2 (de) * 1997-05-27 2006-07-13 Sanofi-Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporalen kreisläufen
ES2312210T3 (es) 1998-06-17 2009-02-16 N.V. Organon Composiciones antitromboticas.
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
MXPA02004741A (es) * 1999-11-12 2003-12-11 Emisphere Tech Inc Formulacion liquida de heparina.
US8600783B2 (en) * 2000-08-18 2013-12-03 The Crawford Group, Inc. Business to business computer system for communicating and processing rental car reservations using web services
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN111057115B (zh) * 2019-12-17 2022-03-22 广东海洋大学 一种从贵妃蚌中提取的抗血栓类肝素及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514659A (en) * 1993-04-22 1996-05-07 Elf Sanofi 3-deoxy oligosaccharides and pharmaceutical compositions containing them
US5543403A (en) * 1990-04-23 1996-08-06 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543403A (en) * 1990-04-23 1996-08-06 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5514659A (en) * 1993-04-22 1996-05-07 Elf Sanofi 3-deoxy oligosaccharides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZA973892B (en) 1998-08-19
RU2183638C2 (ru) 2002-06-20
SG55310A1 (en) 1998-12-21
DE69711505D1 (de) 2002-05-08
KR100443802B1 (ko) 2004-10-08
AU2008697A (en) 1997-11-13
TR199700354A3 (tr) 1997-11-21
SG46779A1 (en) 1998-01-20
BRPI9703099A (pt) 1998-09-08
CA2204204A1 (en) 1997-11-08
HU9700852D0 (en) 1997-06-30
HU226370B1 (en) 2008-09-29
DE69711505T2 (de) 2002-09-26
CZ138697A3 (cs) 1998-02-18
HUP9700852A3 (en) 1998-08-28
ATE215547T1 (de) 2002-04-15
NO308251B1 (no) 2000-08-21
PT818459E (pt) 2002-08-30
CN1169433A (zh) 1998-01-07
KR19980018097A (ko) 1998-06-05
IL120722A0 (en) 1997-08-14
NO972120L (no) 1997-11-10
NO972120D0 (no) 1997-05-07
NZ314745A (en) 1998-09-24
CN1115345C (zh) 2003-07-23
IL120722A (en) 1999-07-14
MX9703365A (es) 1998-06-30
EP0818459A2 (en) 1998-01-14
EP0818459B1 (en) 2002-04-03
EP0818459A3 (en) 1998-04-29
JPH1045805A (ja) 1998-02-17
PL183469B1 (pl) 2002-06-28
BRPI9703099B1 (pt) 2016-07-19
CA2204204C (en) 2006-02-28
TR199700354A2 (xx) 1997-11-21
HK1004399A1 (en) 1998-11-27
ES2176609T3 (es) 2002-12-01
TW498078B (en) 2002-08-11
CZ292439B6 (cs) 2003-09-17
PL319843A1 (en) 1997-11-10
DK0818459T3 (da) 2002-07-01
HUP9700852A2 (en) 1997-12-29
BRPI9703099B8 (pt) 2021-07-06
US5872110A (en) 1999-02-16
JP4201360B2 (ja) 2008-12-24
ID17932A (id) 1998-02-12
AR007052A1 (es) 1999-10-13

Similar Documents

Publication Publication Date Title
US5543403A (en) Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
KR100855331B1 (ko) 혈관형성 억제 활성을 가지며 응고억제 효과는 없는,헤파라나제 억제제로서 부분적으로 탈황산화된글리코스아미노글리칸의 유도체
KR20030055269A (ko) 바이오틴 또는 바이오틴 유도체와의 1 이상의 공유 결합을포함하는 항혈전 활성이 있는 다당류
US5705489A (en) Bisconjugates comprising two saccharides and a spacer
AU711630B2 (en) Carbohydrate derivatives
EP0529715A1 (en) Sulfated glycosaminoglycanoid derivatives
US6528497B1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
HU226685B1 (en) Carbohydrate derivatives and pharmaceutical compns. contg. them
KR100533565B1 (ko) 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물
US5773605A (en) Sulfated glycosaminoglycanoid derivatives of the heparin sulfate type
US7919614B2 (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
US5529985A (en) Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5668274A (en) Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
MXPA97003365A (en) Carbohydr derivatives
PL212357B1 (pl) Zmodyfikowana heparyna, jej zastosowanie i zawierająca ją kompozycja farmaceutyczna

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: AKZO NOBEL N.V., SANOFI-SYNTHELABO

Free format text: FORMER OWNER WAS: AKZO NOBEL N.V., SANOFI S.A.

PC Assignment registered

Owner name: SANOFI-SYNTHELABO

Free format text: FORMER OWNER WAS: AKZO NOBEL N.V., SANOFI-SYNTHELABO